Viridian Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2012
Revenue	0.31	1.77	2.96	1.05	4.46	8.39	4	3.48	2.54	4.32	Upgrade
Revenue Growth (YoY)	-82.28%	-40.20%	182.19%	-76.46%	-46.80%	109.49%	15.13%	37.00%	-41.25%	0.09%	Upgrade
Cost of Revenue	0	0	0	0	0	0	0	0	2.47	3.37	Upgrade
Gross Profit	0.31	1.77	2.96	1.05	4.46	8.39	4	3.48	0.07	0.95	Upgrade
Selling, General & Admin	95	35.18	25.81	13.27	11.65	11.05	10.91	6.77	10.25	7.57	Upgrade
Research & Development	159.77	100.89	56.89	28.3	34.79	30.42	19.62	13.69	1	0.35	Upgrade
Other Operating Expenses	0	0	0	69.86	0	0	0	0	0	-0.1	Upgrade
Operating Expenses	254.76	136.08	82.69	111.43	46.44	41.47	30.54	20.46	11.25	7.82	Upgrade
Operating Income	-254.45	-134.3	-79.73	-110.38	-41.98	-33.08	-26.53	-16.99	-11.19	-6.87	Upgrade
Interest Expense / Income	1.85	0.49	0	0.51	0.84	0.87	0.38	0.33	0.14	1.02	Upgrade
Other Expense / Income	-18.56	-4.92	-0.32	-0.17	-0.94	-1.25	-0.4	-0.04	-	-1.25	Upgrade
Pretax Income	-237.73	-129.87	-79.41	-110.72	-41.87	-32.7	-26.51	-17.27	-11.33	-6.64	Upgrade
Net Income	-237.73	-129.87	-79.41	-110.72	-41.87	-32.7	-26.51	-17.27	-11.33	-6.64	Upgrade
Preferred Dividends	0	0	0	0	0	0	0.01	0.05	0	0	Upgrade
Net Income Common	-237.73	-129.87	-79.41	-110.72	-41.87	-32.7	-26.52	-17.32	-11.33	-6.64	Upgrade
Shares Outstanding (Basic)	45	32	12	4	2	2	1	0	0	0	Upgrade
Shares Outstanding (Diluted)	45	32	12	4	2	2	1	0	0	0	Upgrade
Shares Change	39.48%	169.22%	235.07%	70.27%	5.87%	53.81%	3034.25%	13.82%	258.53%	1028.35%	Upgrade
EPS (Basic)	-5.31	-4.05	-6.66	-31.13	-20.04	-16.50	-20.70	-423.15	-315.30	-787.11	Upgrade
EPS (Diluted)	-5.31	-4.05	-6.66	-31.13	-20.04	-16.50	-20.70	-423.15	-315.30	-787.11	Upgrade
Free Cash Flow	-185.07	-94.64	-54.84	-29.82	-36.14	-27.29	-28.41	-15.01	-7.02	-2.48	Upgrade
Free Cash Flow Per Share	-4.13	-2.95	-4.60	-8.38	-17.30	-13.83	-22.15	-366.56	-195.22	-247.13	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	2.60%	22.08%	Upgrade
Operating Margin	-81035.03%	-7579.23%	-2690.79%	-10512.38%	-941.02%	-394.51%	-662.80%	-488.55%	-440.78%	-158.96%	Upgrade
Profit Margin	-75711.46%	-7329.23%	-2680.16%	-10544.29%	-938.65%	-389.97%	-662.43%	-498.22%	-446.34%	-153.70%	Upgrade
Free Cash Flow Margin	-58938.85%	-5340.58%	-1850.83%	-2840.10%	-810.13%	-325.41%	-709.79%	-431.55%	-276.64%	-57.38%	Upgrade
EBITDA	-235.32	-129.1	-79.39	-109.97	-40.75	-31.55	-25.82	-16.61	-11	-5.47	Upgrade
EBITDA Margin	-74941.72%	-7285.38%	-2679.45%	-10473.14%	-913.47%	-376.21%	-645.04%	-477.62%	-433.53%	-126.69%	Upgrade
Depreciation & Amortization	0.57	0.29	0.02	0.24	0.29	0.28	0.31	0.34	0.18	0.14	Upgrade
EBIT	-235.89	-129.39	-79.41	-110.21	-41.04	-31.83	-26.13	-16.95	-11.19	-5.62	Upgrade
EBIT Margin	-75123.25%	-7301.81%	-2680.05%	-10495.90%	-919.93%	-379.56%	-652.74%	-487.43%	-440.78%	-130.02%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).